Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?
ABSTRACT Objective This study was designed to compare the serum levels of fibroblast growth factor 23 (FGF23) among patients with gestational diabetes mellitus (GDM) and healthy pregnant women, and to evaluate the association between hormonal and metabolic parameters. Subjects and methods A tota...
Gorde:
| Egile Nagusiak: | , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Sociedade Brasileira de Endocrinologia e Metabologia
2017-09-01
|
| Saila: | Archives of Endocrinology and Metabolism |
| Gaiak: | |
| Sarrera elektronikoa: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972017000600562&lng=en&tlng=en |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|